急性胆碱能危象恢复后迟发性有机磷神经病:一项前瞻性观察研究
出院时(中位6天,IQR 3–10天)除1例外神经查体和NCS均正常;随访6个月内8例(34.8%)发生有机磷诱导的迟发性神经病(OPIDN),其中3例有症状、5例仅NCS发现亚临床周围神经受累,全部与氯吡硫磷摄入相关(17例氯吡硫磷中毒中8例)。2例在3个月时足下垂和步态共济失调并持续至6个月,1例3个月时远端感觉异常至6个月随访改善;OPIDN病例NCS均显示轴索变性、运动纤维受累重于感觉纤维、腓神经常受累。基线特征(包括摄入量)单因素分析均不能预测氯吡硫磷自服患者临床或亚临床OPIDN。
要点
- OPIDN全部见于氯吡硫磷中毒者(8/17例氯吡硫磷病例),其他有机磷中毒者未见OPIDN。
- 2例OPIDN在3个月时出现足下垂和步态共济失调,至6个月仍持续存在;1例远端感觉异常在6个月随访时改善。
- 出院时(中位6天)除1例外神经查体和NCS正常,提示早期NCS正常不能排除后续OPIDN。
- 基线特征包括摄入量在单因素分析中均不能预测氯吡硫磷自服患者的临床或亚临床OPIDN。
适用人群与场景
- 年龄13–40岁、因急性有机磷摄入至印度北部一家学术医院就诊的患者。
- 在胆碱能危象缓解后纳入随访,随访6个月。
诊断标准与关键阈值
- OPIDN诊断依据随访期间神经系统病史、神经查体和神经传导检查(NCS);NCS在OPIDN病例中均显示轴索变性、运动纤维受累重于感觉纤维、腓神经常受累。
- 原文未提及OPIDN的具体诊断标准名称或评分界值。
处置流程与药物剂量
- 原文未提及胆碱能危象的具体治疗方案或药物剂量。
- 胆碱能危象缓解后出院,中位出院时间6天(IQR 3–10天),出院时进行神经查体和NCS。
- 出院后随访6个月,进行神经系统评估(病史、神经查体)和NCS。
红旗征与不能漏的情况
- 氯吡硫磷自服中毒胆碱能危象恢复后,随访期间出现足下垂、步态共济失调或远端感觉异常,提示OPIDN,部分症状可持续至6个月。
- NCS发现亚临床周围神经轴索损害(运动纤维重于感觉纤维、腓神经常受累),可能提示后续症状性神经病。
研究设计与关键结果
- 主要结果:随访6个月内8例(34.8%)发生OPIDN,其中3例有症状、5例NCS检出亚临床周围神经受累。
- OPIDN全部与氯吡硫磷摄入相关(8/17例氯吡硫磷中毒病例);2例在3个月时足下垂和步态共济失调并持续至6个月;1例远端感觉异常在6个月随访时改善。
- 出院时(中位6天,IQR 3–10天)除1例外神经查体和NCS均正常。
- OPIDN病例NCS均显示轴索变性、运动纤维受累重于感觉纤维、腓神经常受累。
- 基线特征(包括摄入量)在单因素分析中均不能预测氯吡硫磷自服患者的临床或亚临床OPIDN。
证据类型、等级与局限
- 证据类型:前瞻性观察研究(原文未给出证据等级或推荐强度)。
- 局限:原文未述局限性。
对床旁实践的改变
- 对氯吡硫磷自服中毒且胆碱能危象已缓解的患者,出院时神经查体和NCS正常不能排除后续OPIDN,应在6个月内随访神经症状和NCS。
- 随访中NCS检出亚临床周围神经损伤可能提供早期窗口以预防严重症状性神经病(原文结论性表述)。
- 基线特征包括摄入量不能预测OPIDN,不能据此筛选高危患者。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Despite organophosphate pesticide is the most prevalent cause of acute poisoning in low- and middle-income countries, data on organophosphate induced delayed neuropathy (OPIDN) are limited. We aimed to characterize organophosphates' long-term effects on the peripheral nervous system after an acute cholinergic crisis in adults.
METHODS: We performed a prospective observational study in an academic hospital of north India in patients aged 13-40 years with acute organophosphate ingestion. After resolving the cholinergic crisis, the patients were followed for six months with neurologic assessments, including history, neurologic examination, and nerve conduction study (NCS).
RESULTS: Twenty-three patients were recruited to the study. All but one had normal neurological examination and NCS at discharge from hospital a median duration of six days (interquartile range, 3-10) after self-poisoning. Eight (34.8%) developed OPIDN during the six-month follow-up. Three patients had symptomatic neuropathy, and NCS detected subclinical peripheral nerve involvement in five. All cases were associated with chlorpyrifos ingestion (8/17 total chlorpyrifos cases). Two OPIDN cases had foot drop and gait ataxia at three-month which persist at six-month. One patient had distal paresthesia at three months, which improved at a six-month follow-up. NCS in OPIDN cases invariably revealed axonal degeneration, injury to motor fibers more than sensory fibers, and frequent peroneal nerve involvement. None of the baseline characteristics, including the ingested amount, predicted clinical or subclinical OPIDN in chlorpyrifos self-poisoned patients on a univariant analysis.
CONCLUSION: Peripheral nerve involvement is not uncommon after recovery from a cholinergic crisis in chlorpyrifos self-poisoning and debilitating in some patients. Detection of subclinical injury on NCS may provide an early window to prevent severe symptomatic neuropathy.
参考来源
- Pannu AK, Bhalla A, Vishnu RI, et al. Organophosphate induced delayed neuropathy after an acute cholinergic crisis in self-poisoning. Clin Toxicol (Phila). 2020. PMID: 33078989. doi:10.1080/15563650.2020.1832233
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。